Sars Cov 2 Causing(非典的 2 起因)研究综述
Sars Cov 2 Causing 非典的 2 起因 - A novel coronavirus known as SARS-CoV-2 causing the human COVID-19 disease, emerged in China and is spreading worldwide. [1] However, further experimental validation is required to confirm their inhibitory activities against SARS-CoV-2 causing COVID-19. [2] SARS-CoV-2 causing COVID-19 initially began in Wuhan, China and now has been declared a pandemic by the World Health Organization (WHO). [3] Participants are non-hospitalised adults with highly suspected COVID-19 within the first 5 days of symptom onset, or who have tested positive with SARS-CoV-2 causing COVID-19 within the first 7 days of symptom onset, or who are asymptomatic but tested positive for SARS-CoV-2 for the first time within the last 48 hours. [4] Rationale: SARS-CoV-2 causing COVID19 has led to a pandemic with over 70 million cases worldwide as well as more than 18 million cases here in the US. [5] Objectives: This is a protocol for a Cochrane Review (intervention) The objectives are as follows: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19;and to maintain the currency of the evidence, using a living systematic review approach Copyright © 2021 The Cochrane Collaboration Published by John Wiley & Sons, Ltd. [6] Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 causing systemic organ dysfunction. [7] SARS-CoV-2 causing COVID-19 emerged in late 2019 and resulted in a devastating pandemic. [8] 1,2 SARS-CoV-2 causing the novel COVID-19 respiratory infectious disease is affecting socioeconomic and healthcare systems globally. [9] At the same time studies are going on to discover vaccine against it or repurposing of approved drugs is widely adopted are under trial to eradicate the SARS-CoV-2 causing COVID-19. [10] In this study, we analyzed virology features of SARS-CoV-2 causing a family cluster outbreak. [11] SARS-CoV-2 causing COVID-19 initially began in Wuhan, China and now has been declared a pandemic by the World Health Organization (WHO). [12] At a time when there is noproven therapy for global pandemic SARS-CoV-2 causing infectious viral disease COVID-19, alternative food and nutritional interventions through diet are studied like never before to limit the infection. [13] The SARS-CoV-2 causing acute respiratory disease COVID-19 is considered a worldwide emergency. [14] SARS-CoV-2 causing coronavirus disease 2019 (COVID-19) is responsible for one of the most deleterious pandemics of our time. [15] In addition to SARS-CoV-2 causing pneumonia, many studies have reported ischemic stroke in patients with COVID-19. [16] Here we describe the modification of this system to efficiently capture specimens from patients with SARS-CoV-2 causing coronavirus disease (COVID-19). [17] Infection by the novel coronavirus SARS-CoV-2 causing the coronavirus disease (COVID-19), is currently a global pandemic with nearly two million deaths to date. [18] The earliest cases of SARS-CoV-2 causing COVID (CO for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease)-19 occurred around 1 December 2019 [1]. [19] To better understand the genes with altered expression caused by infection with the novel coronavirus strain SARS-CoV-2 causing COVID-19 infectious disease, a tensor decomposition (TD)-based unsupervised feature extraction (FE) approach was applied to a gene expression profile dataset of the mouse liver and spleen with experimental infection of mouse hepatitis virus, which is regarded as a suitable model of human coronavirus infection. [20] TOPIC: Chest Infections TYPE: Medical Student/Resident Case Reports INTRODUCTION: The SARS-CoV-2 causing COVID-19 can have serious effects on the heart with recent data suggesting acute cardiac injury in almost one fifth of COVID-19 patients. [21] Three pathogenic human coronaviruses have emerged within the last 20 years, with SARS-CoV-2 causing a global pandemic. [22] This case highlights the potential of SARS-CoV-2 causing direct mitral valve damage resulting in severe mitral valve insufficiency with subsequent pulmonary oedema and respiratory failure. [23] Objective: to point out the importance of nuclear medicine for the diagnosis and therapy of COVID-19, in addition to reporting the efficacy of treatment with radioisotopes (sodium pertechnetate and iodine 131) in individuals infected with SARS-CoV-2 causing viral sterility and preventing its mutagenesis and ensuring the absence of adverse reactions. [24] CONCLUSIONS Studies on mechanisms whereby SARS-CoV-2 causing liver damages might provide more information about the pathogenesis of COVID-19 and help management of this global health emergency. [25] It also includes a focus on ALI cultures described in literature studying respiratory viruses such as SARS-CoV-2 causing the global Covid-19 pandemic at the time of writing this review. [26] Therefore, much research is needed to explain the involvement of SARS-CoV-2 causing these neurological symptoms because scientists know zero about it. [27] The emergence and spread of the novel corona virus SARS-CoV-2 causing pneumonia and severe respiratory tract infections has put the whole world in grave situation. [28] This study investigates the role of children in spreading SARS-CoV-2 causing COVID-19 within family clusters in Oman. [29]一种名为 SARS-CoV-2 的新型冠状病毒导致人类 COVID-19 疾病，在中国出现并正在全球传播。 [1] 然而，需要进一步的实验验证来确认它们对引起 COVID-19 的 SARS-CoV-2 的抑制活性。 [2] 引起 COVID-19 的 SARS-CoV-2 最初始于中国武汉，现在已被世界卫生组织 (WHO) 宣布为大流行病。 [3] 参与者是在症状出现的前 5 天内高度怀疑 COVID-19 的未住院成人，或在症状出现的前 7 天内检测出导致 COVID-19 的 SARS-CoV-2 呈阳性，或无症状但在过去 48 小时内首次检测出 SARS-CoV-2 呈阳性。 [4] 理由：引起 COVID19 的 SARS-CoV-2 导致了一场大流行，全球有超过 7000 万例病例，美国也有超过 1800 万例病例。 [5] 目标：这是一项 Cochrane 评价（干预）方案 目标如下：评估 SARS-CoV-2 中和 mAb（包括 mAb 片段）的有效性和安全性，以防止感染导致 COVID 的 SARS-CoV-2 -19；并保持证据的流通性，使用实时系统评价方法 版权所有 © 2021 The Cochrane Collaboration 由 John Wiley & Sons, Ltd. 出版。 [6] 儿童多系统炎症综合征 (MIS-C) 是 SARS-CoV-2 引起全身器官功能障碍的严重并发症。 [7] 导致 COVID-19 的 SARS-CoV-2 于 2019 年底出现，并导致了毁灭性的大流行。 [8] 1,2 引起新型 COVID-19 呼吸道传染病的 SARS-CoV-2 正在影响全球的社会经济和医疗保健系统。 [9] 与此同时，正在进行研究以发现针对它的疫苗或重新利用已被广泛采用的已批准药物，以根除引起 COVID-19 的 SARS-CoV-2。 [10] 在这项研究中，我们分析了导致家庭集群爆发的 SARS-CoV-2 的病毒学特征。 [11] 引起 COVID-19 的 SARS-CoV-2 最初始于中国武汉，现在已被世界卫生组织 (WHO) 宣布为大流行病。 [12] 在全球流行病 SARS-CoV-2 导致传染性病毒性疾病 COVID-19 尚无经过验证的治疗方法之际，通过饮食进行的替代食物和营养干预以前所未有的方式进行了研究，以限制感染。 [13] 引起急性呼吸道疾病 COVID-19 的 SARS-CoV-2 被认为是全球紧急情况。 [14] 引起 2019 年冠状病毒病 (COVID-19) 的 SARS-CoV-2 是我们这个时代最有害的流行病之一。 [15] 除了引起肺炎的 SARS-CoV-2 外，许多研究报告了 COVID-19 患者的缺血性中风。 [16] 在这里，我们描述了对该系统的修改，以有效地从导致冠状病毒病 (COVID-19) 的 SARS-CoV-2 患者身上采集样本。 [17] 由新型冠状病毒 SARS-CoV-2 引起的冠状病毒病 (COVID-19) 感染目前是全球大流行病，迄今已有近 200 万人死亡。 [18] 最早引起 COVID 的 SARS-CoV-2 病例（CO 表示“冠状病毒”，“VI”表示“病毒”，“D”表示疾病）-19 发生在 2019 年 12 月 1 日左右 [1]。 [19] 为了更好地了解由感染导致 COVID-19 传染病的新型冠状病毒株 SARS-CoV-2 引起的表达改变的基因，将基于张量分解 (TD) 的无监督特征提取 (FE) 方法应用于基因表达谱实验性感染小鼠肝炎病毒的小鼠肝脾数据集，被认为是人类冠状病毒感染的合适模型。 [20] 主题：胸部感染 类型：医学生/住院医师病例报告 简介：导致 COVID-19 的 SARS-CoV-2 会对心脏产生严重影响，最近的数据表明，近五分之一的 COVID-19 患者有急性心脏损伤。 [21] 在过去 20 年中出现了三种致病性人类冠状病毒，其中 SARS-CoV-2 引起了全球大流行。 [22] 该病例凸显了 SARS-CoV-2 可能导致直接二尖瓣损伤，导致严重的二尖瓣关闭不全，随后出现肺水肿和呼吸衰竭。 [23] 目的：指出核医学对 COVID-19 诊断和治疗的重要性，此外还报告了放射性同位素（高锝酸钠和碘 131）对感染 SARS-CoV-2 的个体的治疗效果，导致病毒不育和防止其诱变并确保没有不良反应。 [24] 结论 对 SARS-CoV-2 引起肝损伤的机制的研究可能会提供有关 COVID-19 发病机制的更多信息，并有助于管理这一全球卫生紧急情况。 [25] 它还包括在撰写本文时研究引起全球 Covid-19 大流行的 SARS-CoV-2 等呼吸道病毒的文献中描述的 ALI 培养物。 [26] 因此，需要大量研究来解释导致这些神经系统症状的 SARS-CoV-2 的参与，因为科学家对此知之甚少。 [27] 引起肺炎和严重呼吸道感染的新型冠状病毒 SARS-CoV-2 的出现和传播使整个世界处于严峻形势。 [28] 本研究调查了儿童在阿曼家庭集群中传播导致 COVID-19 的 SARS-CoV-2 中的作用。 [29]